Posterior reversible encephalopathy syndrome in a patient of organophosphate poisoning.

Autor: Phatake R; Lifeline24 × 7Intensive Care Unit, Hubli, Karnataka, India., Desai S; Department of Anesthesiology, SDM Medical College Hospital, Dharwar, India., Lodaya M; Lifeline24 × 7Intensive Care Unit, Hubli, Karnataka, India., Deshpande S; Lifeline24 × 7Intensive Care Unit, Hubli, Karnataka, India., Tankasali N; Lifeline24 × 7Intensive Care Unit, Hubli, Karnataka, India.
Jazyk: angličtina
Zdroj: Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine [Indian J Crit Care Med] 2014 Apr; Vol. 18 (4), pp. 250-2.
DOI: 10.4103/0972-5229.130580
Abstrakt: A 32-year-old male presented with a history of consuming some organophosphorous compound with suicidal intention. He was treated with atropine, pralidoxime, ventilator support. During stay patient had persistent irritability, tachycardiaand hypertension despite sedation and labetalol infusion. He developed headache, visual blurring hemiparesis and focal seizures. Magnetic resonance imaging of the brain revealed multifocal hyperintensities mainly in subcortical areas of parietal and occipital regions in T2-weighted images, with increased values of Apparent Diffusion Coefficient, suggesting posterior reversible encephalopathy syndrome (PRES). The possibilities of PRES caused by organophosphorous poisoning either due to hypertension caused by autonomic deregulation or direct neurological toxicity has been discussed.
Databáze: MEDLINE